Ahmedabad-based Nirma is set to acquire Glenmark Life Sciences (GLS), a subsidiary of Glenmark Pharma, for Rs 5,652 crore. This move marks Nirma's entry into the active pharmaceutical ingredient (API) sector and expands its pharmaceutical portfolio, which includes injectables, parentals, and ophthalmic products. GLS specializes in developing APIs for various therapeutic segments.
from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/jqkJCUz
Subscribe to:
Post Comments (Atom)
Microsoft-backed cloud platform ‘will bully Indians to agree with it’: Ola CEO
Bhavish Aggarwal, the founder and CEO of Ola, announced the company's move to shift its workloads from Microsoft's Azure to its prop...
-
A woman, in her early 20s, was stabbed to death by a man in southeast Delhi's Bhogal area on Friday evening, following which the accused...
-
The Delhi High Court on Thursday dismissed the pleas of TTV Dhinakaran and VK Sasikala challenging the Election Commission's order grant...
-
Trading in stock markets this week will be majorly influenced by the upcoming quarterly earnings from IT majors TCS and Infosys, along with...
No comments:
Post a Comment